FET Biosensor with Hydrophobic Layer for Real-Time Biomarker Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current clinical assay platforms for measuring biomarkers, such as those for central nervous system (CNS) injury, are limited by their inability to provide real-time monitoring, which restricts the therapeutic window for treatment during procedures like cardiac surgery, and there is a need for continuous detection of biomarkers and anticoagulation drugs like heparin to prevent complications.
Innovation Solution
Development of biosensor systems using field effect transistors (FETs) with a fluoropolymer and hydrophobic layers, capable of detecting changes in electrical properties to identify analytes such as GFAP in real-time, allowing for continuous monitoring in aqueous and biological environments.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If ELISA-based clinical assay platforms are used to measure biomarkers, then measurement precision can be achieved, but the assay time is at least 30 minutes which significantly limits the therapeutic window for treatment
Solution Approach 1:
The patent replaces traditional mechanical/chemical ELISA assay systems with an electronic field-effect transistor (FET) based biosensor system. The FET detector uses electrical field interactions to detect biomarker binding events in real-time, eliminating the need for lengthy incubation and washing steps required by ELISA methods. This substitution of detection mechanism enables continuous monitoring with response times reduced from minutes to seconds, directly resolving the time-precision contradiction.
2Reliability
If continuous monitoring of biomarkers is implemented, then the therapeutic window for treatment is improved, but the device complexity increases with multiple layers including passive layer, hydrophobic layer, and receptor-attachment material
Solution Approach 1:
The patent implements a nested multi-layer structure where each layer serves a specific function: the passive layer (fluoropolymer) provides the base coating, the hydrophobic layer is deposited upon it to create analyte-repellent properties, and the receptor-attachment material is applied to the hydrophobic layer for specific biomarker binding. This nested arrangement allows continuous monitoring capability while organizing complexity into functional modules, making the system manageable and manufacturable.
Solution Approach 2:
The sensor employs composite material construction combining fluoropolymer passive layer with hydrophobic material coating and receptor-attachment chemistry. This composite approach enables the sensor to simultaneously achieve chemical inertness, hydrophobicity for non-specific binding prevention, and specific receptor binding capability, resolving the reliability-complexity contradiction by integrating multiple functions into a unified composite structure.
3Productivity
If real-time detection of multiple analytes is achieved, then patient care and procedure safety are improved, but the manufacturing precision requirements increase for creating functional layers with specific properties
Solution Approach 1:
The patent utilizes parameter changes in the deposition process, particularly controlling the thickness and properties of the hydrophobic layer through vapor deposition parameters. By optimizing deposition time, temperature, and material flux, the system achieves real-time detection capability while maintaining manufacturable precision requirements. The parameter control allows tuning of layer properties to balance detection sensitivity with manufacturing feasibility.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables real-time detection of biomarkers and drugs like heparin, improving patient care and procedure safety by providing timely intervention and reducing mortality and morbidity risks associated with CNS injury and anticoagulation.
Implementation Method 1
a detector configured to detect a change in an electrical property on a surface of the detector. In a representative, non-limiting example, the detector may be a field effect transistor
Implementation Method 2
a hydrophobic layer disposed on the passive layer. The hydrophobic layer may be, for example, a vapor-deposited hydrophobic material
Implementation Method 3
a receptor-attachment material disposed on the hydrophobic layer and configured for binding to an analyte. One or more receptors may bind to the analyte
Data Source
AI summary
Disclosed herein are biosensor systems and related methods for detecting analytes in aqueous and biologic environments. A biosensor system for detecting binding of an analyte of interest may include a detector configured to detect a change in an electrical property on a surface thereof. The detector may be a FET. The system also may include a passive layer disposed on a top surface of the detector. Further, the system may include a hydrophobic layer disposed on the passive layer. The system also may include a receptor-attachment material configured for binding to an analyte. A receptor may bind to the analyte, and the receptor may be attached to the receptor-attachment material. The binding of the analyte to the receptor can cause the change of the electrical property at the surface. In response to the change for example, a current may change for indicating the binding of the analyte to the receptor.